Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2022 May 1;90(1):97–105. doi: 10.1097/QAI.0000000000002922

Table 2.

Cox proportional hazard models for time to neurocognitive decline comparing Latino and White people with HIV (Model A) and Latinos and Black people with HIV (Model B)

Model A Predictor Reference Risk HR (95% CI) P Value

Model 1A

Ethnicity/race White Latino 2.25 [1.35, 3.73] 0.002

Model 2A

Ethnicity/race White Latino 1.83 [1.06, 3.16] 0.03
Hematocritc 1 unita Lower 1.08 [1.02, 1.14] 0.006
Comorbidity Contributing Confounding 3.16 [1.44, 6.93] 0.004
Comorbidity Incidental Confounding 3.38 [1.69, 6.73] <0.001
Total Cholesterolc 1 unita Lower 1.01 [1.00, 1.02] 0.04
Triglyceridesc 1 unitb Higher 1.00 [1.00, 1.03] 0.07

Model B Predictor Reference Risk HR (95% CI) P Value

Model 1B

Ethnicity/race Black Latino 1.86 [1.14, 3.04] 0.013

Model 2B

Ethnicity/race Black Latino 2.39 [1.34, 4.19] 0.002
Nadir CD4 1 sqrtb Higher 1.04 [1.00, 1.07] 0.06
Hematocritc 1 unita Lower 1.08 [1.02, 1.14] 0.009
Diabetesc No Yes 1.69 [0.85, 3.34] 0.13
Urine toxicologyc Negative Positive 1.61 [0.91, 2.87] 0.10

Abbreviations: HR, hazard ratio; CI, confidence interval; sqrt, square root transformation; CD4, cluster of differentiation 4; Comorbidity, Neurocognitive Comorbidity Status; LT Meth SUD, lifetime methamphetamine substance use disorder

Notes:

a

Higher

b

Lower

c

Variable modelled in a time-dependent manner